Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence

Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including dulaglutide, liraglutide, semaglutide, and exenatide, are effective treatments for type 2 diabetes mellitus (T2DM) and obesity. These agents mimic the action of the endogenous incretin glucagon-like peptide-1 (GLP-1) by enhancing insuli...

Full description

Saved in:
Bibliographic Details
Main Authors: Lívia C. R. Teixeira, Marcelo R. Luizon, Karina B. Gomes
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Receptors
Subjects:
GLP-1 receptor
GLP-1 receptor agonists
Alzheimer’s disease
type 2 diabetes mellitus
Online Access:https://www.mdpi.com/2813-2564/4/1/2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items